|
⚲
|
| Keyboard |
| Rastetter William H
✚
|
|
|---|---|
| CIK # | 0001205903 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001205903] | |
| 4 | [0001205903] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dare Bioscience Inc | |
| Rastetter William H | |
| Fate Therapeutics Inc | |
| Neurocrine Biosciences Inc | |
| Regulus Therapeutics Inc | |
| Illumina Inc | |
| Receptos Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-11-05 | Sell | 18,000 | $151.82 | 2,732,760 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2025-11-05 | Option exercise | 18,000 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-11-05 | Option exercise | 18,000 | $47.89 | 862,020 |
|
Dare Bioscience Inc DARE
Stock Option (right to buy) · derivative
|
2025-07-09 | Grant | 4,500 | $0.00 | |
|
Regulus Therapeutics Inc RGLS
Stock Option · derivative
|
2025-06-25 | Disposed to issuer | 9,000 | ||
|
Regulus Therapeutics Inc RGLS
Common Stock
|
2025-06-25 | Tender | 44,264 | ||
|
Regulus Therapeutics Inc RGLS
Common Stock
|
2025-06-25 | Disposed to issuer | 57,292 | ||
|
Regulus Therapeutics Inc RGLS
Stock Option · derivative
|
2025-06-25 | Disposed to issuer | 2,325 | ||
|
Regulus Therapeutics Inc RGLS
Stock Option · derivative
|
2025-06-25 | Disposed to issuer | 4,650 | ||
|
Regulus Therapeutics Inc RGLS
Stock Option · derivative
|
2025-06-25 | Disposed to issuer | 4,000 | ||
|
Regulus Therapeutics Inc RGLS
Stock Option · derivative
|
2025-06-25 | Disposed to issuer | 30,000 | ||
|
Regulus Therapeutics Inc RGLS
Stock Option · derivative
|
2025-06-25 | Disposed to issuer | 15,000 | ||
|
Regulus Therapeutics Inc RGLS
Stock Option · derivative
|
2025-06-25 | Disposed to issuer | 30,000 | ||
|
Regulus Therapeutics Inc RGLS
Stock Option · derivative
|
2025-06-25 | Disposed to issuer | 60,000 | ||
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2025-05-29 | Grant | 55,000 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-05-22 | Option exercise | 2,869 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-22 | Option exercise | 2,869 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-21 | Grant | 3,318 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-05-05 | Option exercise | 30,000 | $42.76 | 1,282,800 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-05-05 | Sell | 30,000 | $110.20 | 3,306,000 |
| showing 20 of 200 most recent transactions | |||||